Fractionating Heparins and Their Clinical Trial Data--Something for Everyone.

Presents an editorial about fractionating heparins. Use of heparins in reducing ischemic events beyond that of aspirin alone in the setting of an acute coronary syndrome; Limitations of unfractionated heparins; Description of enoxaparin, a low-molecular-weight heparin; Results of clinical trials of enoxaparin; Reference to studies in this issue focusing on enoxaparin trials; Assertion that enoxaparin is an effective, noninferior alternative to unfractionated heparin for treatment of acute coronary syndrome.